Growth and reproductive traits in beef heifers implanted with zeranol.
Weaned replacement heifers were implanted with zeranol at 8 and 11 mo of age in two trials to evaluate growth and reproductive traits. Approximately 100 beef heifers were used in each trial, and the heifers were divided into categories of heavier than average (H) and lighter than average (L) weaning weight. Weight categories were further divided into control (HC and LC) and zeranol-implanted (HI and LI) groups. Heifers were kept in drylot from weaning to just before the start of the breeding season and were fed to reach a predetermined body weight by the start of the breeding season and were fed to reach a predetermined body weight by the start of the breeding season. Rates of gain in the drylot were greater in implanted than in control heifers in both trial 1 (.53 vs .48 kg/d; P less than .09) and trial 2 (.70 vs .63 kg/d; P less than .01). Pelvic areas were greater (P less than .01) in implanted than in control heifers of both trial 1 (175 vs 159 cm2) and trial 2 (175 vs 164 cm2). This increase in pelvic size was still present at the end of the summer pasture period, which followed the drylot period. Zeranol had no major effect (P greater than .10) on age of weight at puberty. Fall pregnancy rate was 16% lower in implanted heifers than in control heifers in trial 1 (62 vs 78%, P = .08) but did not differ in trial 2 (88 vs 87%, I and C, respectively).
D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D002417:Cattle / Q000254:growth & development / Q000502:physiology*; D004343:Drug Implants; D005260:Female; D012098:Reproduction / Q000187:drug effects*; D012118:Resorcinols / Q000494:pharmacology*; D014886:Weaning; D015029:Zeranol / Q000494:pharmacology*
D004343:Drug Implants; D012118:Resorcinols; D015029:Zeranol